Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease

Basic Research in Cardiology

Volumn 102, Issue 6, 2007, Pages 565-571

  Werner, Nikos ^a   Wassmann, Sven ^a   Ahlers, Patrick ^a   Schiegl, Tobias ^a   Kosiol, Sonja ^a   Link, Andreas ^b   Walenta, Katrin ^b   Nickenig, Georg ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Endothelial function; Endothelial progenitor cells

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CD133 ANTIGEN; CD34 ANTIGEN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CELL COUNT; CELL ISOLATION; COLONY FORMING UNIT E; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; FUNCTIONAL ASSESSMENT; HIGH RISK PATIENT; HUMAN; HUMAN CELL; INTRACORONARY INFUSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MULTIVARIATE ANALYSIS; PATHOGENESIS; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; STEM CELL; UNIVARIATE ANALYSIS;

EID: 35348842090     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-007-0680-1     Document Type: Article

References (30)

1. Asahara T, Murohara T, Sullivan A, Silver M, Van der ZR, Li T, Witzenbichler B, Schatteman G, Isner JM (1997)Isolation of putative progenitor endothelialcells for angiogenesis. Science275:964-967
2. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, HoelzerD, Dimmeler S, Zeiher AM (2002) Transplantation of Progenitor Cells and Regeneration Enhancement in AcuteMyocardial Infarction (TOPCAREAMI). Circulation 106:3009-3017
3. Baumhäkel M, Werner N, Böhm M, Nickenig G (2006) Circulating endothelialprogenitor cells correlate with erectilefunction in patients with coronaryheart disease. Eur Heart J 27:2184-2188
4. Fontaine V, Filipe C, Werner N, Gourdy P, Billon A, Garmy-Susini B, Brouchet L, Bayard F, Prats H, Doetschman T, Nickenig G, Arnal JF (2006) Essential role ofbone marrow fibroblast growth factor-2 in the effect of estradiol on reendothelializationand endothelial progenitorcell mobilization. Am J Pathol169:1855-1862
5. Friedrich EB, Walenta K, Scharlau J,Nickenig G, Werner N (2006) CD34-/ CD133+/VEGFR-2+ endothelial progenitorcell subpopulation with potentvasoregenerative capacities. Circ Res98:e20-e25
6. Heeschen C, Lehmann R, Honold J, AssmusB, Aicher A, Walter DH, Martin H,Zeiher AM, Dimmeler S (2004) Profoundlyreduced neovascularization capacityof bone marrow mononuclearcells derived from patients with chronicischemic heart disease. Circulation 109:1615-1622
7. Heitzer T, Schlinzig T, Krohn K, MeinertzT, Munzel T (2001) Endothelialdysfunction, oxidative stress, and riskof cardiovascular events in patientswith coronary artery disease. Circulation104:2673-2678
8. Hill JM, Zalos G, Halcox JP, SchenkeWH, Waclawiw MA, Quyyumi AA,Finkel T (2003) Circulating endothelialprogenitor cells, vascular function, andcardiovascular risk. N Engl J Med 348:593-600
9. Landmesser U, Hornig B, Drexler H(2004) Endothelial function: A criticaldeterminant in atherosclerosis? Circulation109:II27-II33
10. Laufs U, Werner N, Link A, Endres M,Wassmann S, Jurgens K, Miche E, Böhm M, Nickenig G (2004) Physical trainingincreases endothelial progenitor cells,inhibits neointima formation, and enhancesangiogenesis. Circulation 109:220-226
11. Libby P (2002) Inflammation in atherosclerosis.Nature 420:868-874
12. Libby P, Sukhova G, Lee RT, Liao JK(1997) Molecular biology of atherosclerosis.Int J Cardiol 62(Suppl 2):S23-S29
13. Lyngbaek S, Schneider M, Hansen JL,Sheikh SP (2007) Cardiac regenerationby resident stem and progenitor cells inthe adult heart. Basic Res Cardiol 102:101-114
14. Rauscher FM, Goldschmidt-ClermontPJ, Davis BH, Wang T, Gregg D, RamaswamiP, Pippen AM, Annex BH,Dong C, Taylor DA (2003) Aging, progenitorcell exhaustion, and atherosclerosis. Circulation 108:457-463
15. Ross R (1999) Atherosclerosis - an inflammatorydisease. N Engl J Med 340:115-126
16. Rossig L, Dimmeler S, Zeiher AM (2001)Apoptosis in the vascular wall and atherosclerosis. Basic Res Cardiol 96:11-22
17. Schachinger V, Britten MB, Zeiher AM(2000) Prognostic impact of coronaryvasodilator dysfunction on adverselong-term outcome of coronary heartdisease. Circulation 101:1899-1906
18. Schachinger V, Erbs S, Elsasser A,Haberbosch W, Hambrecht R,Holschermann H, Yu J, Corti R, MatheyDG, Hamm CW, Suselbeck T, Assmus B,Tonn T, Dimmeler S, Zeiher AM (2006)Intracoronary bone marrow-derivedprogenitor cells in acute myocardial infarction. N Engl J Med 355:1210-1221
19. Strauer BE, Brehm M, Zeus T, KosteringM, Hernandez A, Sorg RV, Kogler G,Wernet P (2002) Repair of infarctedmyocardium by autologous intracoronarymononuclear bone marrow cell transplantation in humans. Circulation106:1913-1918
20. Strehlow K,Werner N, Berweiler J, LinkA, Dirnagl U, Priller J, Laufs K,Ghaeni L,Milosevic M, Böhm M, Nickenig G(2003) Estrogen increases bone marrow-derived endothelial progenitor cellproduction and diminishes neointimaformation. Circulation 107:3059-3065
21. Suwaidi JA, Hamasaki S, Higano ST,Nishimura RA, Holmes DR, Jr., LermanA (2000) Long-term follow-up of patientswith mild coronary artery diseaseand endothelial dysfunction. Circulation101:948-954
22. Urbich C, Dimmeler S (2004) Endothelialprogenitor cells: characterizationand role in vascular biology. Circ Res95:343-353
23. Vasa M, Fichtlscherer S, Aicher A, AdlerK, Urbich C, Martin H, Zeiher AM, DimmelerS (2001) Number and migratoryactivity of circulating endothelial progenitorcells inversely correlate withrisk factors for coronary artery disease.Circ Res 89:E1-E7
24. Walter DH, Rittig K, Bahlmann FH,Kirchmair R, Silver M, Murayama T,Nishimura H, Losordo DW, Asahara T,Isner JM (2002) Statin therapy acceleratesreendothelialization: A novel effectinvolving mobilization and incorporationof bone marrow-derived endothelialprogenitor cells. Circulation 105:3017-3024
25. Wassmann S, Nickenig G (2003) Inter-relationshipof free oxygen radicals andendothelial dysfunction-modulationby statins. Endothelium 10:23-33
26. Wassmann S, Werner N, Czech T, NickenigG (2006) Improvement of endothelialfunction by systemic transfusion ofvascular progenitor cells. Circ Res 99:e74-e83
27. Werner N, Junk S, Laufs U, Link A, WalentaK, Böhm M, Nickenig G (2003) Intravenoustransfusion of endothelialprogenitor cells reduces neointima formationafter vascular injury. Circ Res93:e17-e24
28. Werner N, Kosiol S, Schiegl T, Ahlers P,Walenta K, Link A, Bähm M, Nickenig G(2005) Circulating endothelial progenitorcells and cardiovascular outcomes.N Engl J Med 353:999-1007
29. Werner N, Nickenig G (2006) Clinicaland therapeutical implications of EPC biology in atherosclerosis. J Cell MolMed 10:318-332
30. Werner N, Nickenig G (2006) Influenceof cardiovascular risk factors on endothelialprogenitor cells: Limitationsfor therapy? Arterioscler Thromb VascBiol 26:257-266